BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24863162)

  • 1. Long-term outcome of Guillain-Barré syndrome in children.
    Roodbol J; de Wit MC; Aarsen FK; Catsman-Berrevoets CE; Jacobs BC
    J Peripher Nerv Syst; 2014 Jun; 19(2):121-6. PubMed ID: 24863162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Post Guillain-Barre Syndrome (GBS) Patients: A Cross Sectional Study.
    Chowdhury IH; Basher A; Habibullah AK; Asfia KN; Pathan FH; Kamal MM
    Mymensingh Med J; 2019 Apr; 28(2):449-455. PubMed ID: 31086165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Residual neuropathy in long-term population-based follow-up of Guillain-Barré syndrome.
    Dornonville de la Cour C; Jakobsen J
    Neurology; 2005 Jan; 64(2):246-53. PubMed ID: 15668421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome in children with Guillain-Barré syndrome.
    Vajsar J; Fehlings D; Stephens D
    J Pediatr; 2003 Mar; 142(3):305-9. PubMed ID: 12640380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical presentation and course of childhood Guillain-Barré syndrome: a prospective multicentre study.
    Korinthenberg R; Schessl J; Kirschner J
    Neuropediatrics; 2007 Feb; 38(1):10-7. PubMed ID: 17607598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of Guillain-Barré syndrome on the close relatives of patients during the first year.
    Bernsen RA; de Jager AE; van der Meché FG; Suurmeijer TP
    J Neurol Sci; 2006 May; 244(1-2):69-75. PubMed ID: 16476450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors and outcomes of Guillain-Barré syndrome with acute myelitis.
    Lin JJ; Hsia SH; Wu CT; Wang HS; Lin KL; Lyu RK
    Pediatr Neurol; 2011 Feb; 44(2):110-6. PubMed ID: 21215910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guillain-Barré syndrome in a child with pain: lessons learned from a late diagnosis.
    Pier DB; Hallbergson A; Peters JM
    Acta Paediatr; 2010 Oct; 99(10):1589-91. PubMed ID: 20456276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The long-term functional status in patients with Guillain-Barré syndrome.
    Rudolph T; Larsen JP; Farbu E
    Eur J Neurol; 2008 Dec; 15(12):1332-7. PubMed ID: 19049550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How Guillain-Barre patients experience their functioning after 1 year.
    Bernsen RA; de Jager AE; van der Meché FG; Suurmeijer TP
    Acta Neurol Scand; 2005 Jul; 112(1):51-6. PubMed ID: 15932357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of the international classification of functioning, disability and health to describe patient-reported disability: a comparison of motor neurone disease, Guillain-Barré syndrome and multiple sclerosis in an Australian cohort.
    Ng L; Khan F
    Disabil Rehabil; 2012; 34(4):295-303. PubMed ID: 21988084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrences, vaccinations and long-term symptoms in GBS and CIDP.
    Kuitwaard K; Bos-Eyssen ME; Blomkwist-Markens PH; van Doorn PA
    J Peripher Nerv Syst; 2009 Dec; 14(4):310-5. PubMed ID: 20021573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Neurological, Behavioral, Functional, Quality of Life, and School Performance Outcomes in Children With Guillain-Barré Syndrome Admitted to PICU.
    Devi AK; Randhawa MS; Bansal A; Angurana SK; Malhi P; Nallasamy K; Jayashree M
    Pediatr Neurol; 2023 Mar; 140():18-24. PubMed ID: 36587490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Imminent respiratory insufficiency in children resulting from Guillain-Barré syndrome].
    de Wit MC; Roodbol J; de Hoog M; Catsman-Berrevoets CE; Jacobs BC
    Ned Tijdschr Geneeskd; 2011; 155(42):A3808. PubMed ID: 22027469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guillain-Barre syndrome in southern Chinese children: 32 year experience in Hong Kong.
    Ma YM; Liu TK; Wong V
    Pediatr Int; 2010 Feb; 52(1):13-9. PubMed ID: 19702649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A variant of Guillain-Barré syndrome with prominent bilateral peripheral facial nerve palsy--facial diplegia and paresthesias].
    Atsumi M; Kitaguchi M; Nishikawa S; Susuki K
    Rinsho Shinkeigaku; 2004 Aug; 44(8):549-52. PubMed ID: 15471093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long term disability and social status change after Guillain-Barré syndrome.
    Bersano A; Carpo M; Allaria S; Franciotta D; Citterio A; Nobile-Orazio E
    J Neurol; 2006 Feb; 253(2):214-8. PubMed ID: 16096809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of neurological sequelae and new-onset symptoms in the long-term follow-up of paediatric Guillain-Barre syndrome: A longitudinal study from India.
    Sugumar K; Chidambaram AC; Gunasekaran D
    J Paediatr Child Health; 2022 Dec; 58(12):2211-2217. PubMed ID: 36054714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a need for long-term follow-up in chronic idiopathic polyneuropathy?
    Rudolph T; Larsen JP; Farbu E
    Acta Neurol Scand; 2009 Nov; 120(5):347-52. PubMed ID: 19744135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Residual fatigue is independent of antecedent events and disease severity in Guillain-Barré syndrome.
    Garssen MP; Van Koningsveld R; Van Doorn PA
    J Neurol; 2006 Sep; 253(9):1143-6. PubMed ID: 16998652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.